Document Detail

Intravenous ciprofloxacin as empirical treatment of febrile neutropenic patients.
MedLine Citation:
PMID:  2589377     Owner:  NLM     Status:  MEDLINE    
A randomized study of treatment with ciprofloxacin combined with benzylpenicillin (CB) versus a standard regimen of netilmicin combined with piperacillin (NP) as first-line empiric therapy was conducted in febrile neutropenic patients. Ninety-six patients were evaluable for determination of efficacy: 50 patients received CB and 46 patients received NP. There was no significant difference between the two groups in terms of age or primary diagnosis. Overall clinical response rate at the end of therapy was 66 percent for CB and 65 percent for NP. Microbiologic assessment revealed more pathogens eradicated by CB (64 percent) and fewer persisting (4 percent) than in the NP group (52 percent eradicated, 13 percent persisting). Only 10 percent of patients in the CB group had treatment-related adverse reactions as opposed to 28 percent of the NP-treated patients; these were predominantly renal impairment and were likely to have been due to the aminoglycoside. Staphylococcus epidermidis was the most commonly isolated pathogen, accounting for 38 percent of all isolates and 30 percent of all patients in whom treatment failed. Although streptococci accounted for 18 percent of the isolated pathogens, no treatment failures or superinfections were due to these organisms. This indicates an advantage of combining ciprofloxacin with benzylpenicillin. We conclude that the CB regimen is as effective as the NP treatment and is associated with fewer side effects.
S M Kelsey; M E Wood; E Shaw; A C Newland
Related Documents :
8150757 - A non-comparative, multicentre study of cefepime in the treatment of serious bacterial ...
2286597 - Comparison of i.v. ofloxacin and piperacillin in the treatment of complicated urinary t...
23666807 - Vector control and foliar nutrition to maintain economic sustainability of bearing citr...
24012437 - The economic impact of individually packaged screws.
9165357 - A prospective follow-up study of acute deep venous thrombosis using colour duplex ultra...
488407 - New therapeutic approach to the hirsute patient.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The American journal of medicine     Volume:  87     ISSN:  0002-9343     ISO Abbreviation:  Am. J. Med.     Publication Date:  1989 Nov 
Date Detail:
Created Date:  1990-01-02     Completed Date:  1990-01-02     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0267200     Medline TA:  Am J Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  274S-277S     Citation Subset:  AIM; IM    
Department of Haematology, London Hospital, Whitechapel, United Kingdom.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Bacteria / isolation & purification
Bacterial Infections / drug therapy*
Ciprofloxacin / administration & dosage*,  adverse effects
Drug Therapy, Combination
Fever / drug therapy*
Infusions, Intravenous
Middle Aged
Netilmicin / administration & dosage
Neutropenia / complications*
Penicillin G / administration & dosage
Piperacillin / administration & dosage
Random Allocation
Reg. No./Substance:
56391-56-1/Netilmicin; 61-33-6/Penicillin G; 61477-96-1/Piperacillin; 85721-33-1/Ciprofloxacin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Treatment of sepsis in patients with neoplastic diseases with intravenous ciprofloxacin.
Next Document:  An update on the efficacy of ciprofloxacin in animal models of infection.